Zepbound 12.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F6W7Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,411
Award facts
- Contract value 100% obligated
- $2,410.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $2,410.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Zepbound (tirzepatide) 12.5 mg/0.5 mL pens. The order, with an ultimate completion date of January 13, 2026, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a routine pharmaceutical procurement supporting the Defense Logistics Agency's Medical Supply Chain operations.
This delivery order is executed under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 31, 2031. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of medications, medical devices, vaccines, and specialized healthcare commodities to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other federal medical institutions. Cencora, Inc. competes on a full and open basis for federal pharmaceutical contracts and has demonstrated significant capability in fulfilling government medical supply requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F6W7Y?
SPE2DR26F6W7Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F6W7Y worth?
The government has obligated $2,411 on SPE2DR26F6W7Y.
Is contract SPE2DR26F6W7Y an order under another contract?
Yes. SPE2DR26F6W7Y is a delivery order under SPE2DR25D3013, an indefinite delivery contract.
Was contract SPE2DR26F6W7Y competed?
The extent of competition for SPE2DR26F6W7Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award